Home 
General Physiology and Biophysics 2024 General Physiology and Biophysics Vol.43, No.5, p, 457–467, 2024
General Physiology and Biophysics 2024 General Physiology and Biophysics Vol.43, No.5, p, 457–467, 2024
Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
General Physiology and Biophysics Vol.43, No.5, p, 457–467, 2024 |
||
| Title: Peripheral nesfatin-1 reduces basal brain activity but has limited effect on epilepsy-like conditions | ||
| Author: Ömer Faruk Kalkan, Osman Aktaş, Zafer Şahin, Selcen Aydin Abidin, Abdulhamit Yildirim, Ali Faruk Özyaşar, İbrahim Uzunand İsmail Abidin | ||
| Abstract: In this study, we investigated the effects of peripheral nesfatin-1 on basal brain activity and 4-aminopyridine (4-AP)-induced epileptiform activity, and its relationship with the electrocorticogram (ECoG) power spectrum and EEG bands. Forty-nine male Wistar rats were divided into seven groups: control sham, 4-AP (2.5 mg/kg i.p.), Nesfatin-1 (1, 2, and 4 µg/kg i.p.), Nesfatin-1 (2 µg/kg) post-treatment, and Nesfatin-1 (2 µg/kg) pre-treatment. Recordings were conducted for 70 min under ketamine/xylazine (90/10 mg/kg) anesthesia. In the post-treatment group, nesfatin-1 was injected 20 min after 4-AP induction. In the pre-treatment groups, nesfatin-1 was administered following basal recordings and before 4-AP injection. 4-AP induced epileptiform activity in all animals, peaking at 30 min. Nesfatin-1 (2 µg/kg) reduced basal brain activity (p 0.05) but increased gamma band activity (p > 0.05). Pre-treatment of nesfatin-1 reduced epileptiform activity between 50 and 60 min (p 0.05). We conclude that peripheral nesfatin-1 modulates normal brain activity but has limited effects on abnormal discharges. |
||
| Keywords: Nesfatin-1 — Neuropeptide — Epilepsy — EEG — 4-Aminopyridine | ||
| Published online: 16-Aug-2024 | ||
| Year: 2024, Volume: 43, Issue: 5 | Page From: 457, Page To: 467 | |
| doi:10.4149/gpb_2024026 |
||
|
|
 download file |
|